| Drs Price Young Odle & Horsch Pa | |
| 109 S 6th St, Ste A, Hiawatha, Kansas 66434 | |
| (636) 200-4393 |
| Name | Drs Price Young Odle & Horsch Pa |
|---|---|
| Organization Name | Drs Price Young Odle & Horsch Pa |
| Location | 109 S 6th St, Ste A, Hiawatha, Kansas 66434 |
| Type | Supplier |
| Phone | (636) 200-4393 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The U.S. Food and Drug Administration today approved a new medical adhesive (a fibrin sealant) called Artiss for use in attaching skin grafts onto burn patients.
The COVID-19 pandemic caused by SARS-CoV-2 has been observed to be less serious in infants and children. However, this age group is also subject to certain complications following infection. A new study describes the findings of an observational study of children hospitalized with SARS-CoV-2 infection in several different hospitals across three countries.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the U.S. Food & Drug Administration (FDA) has provided Orphan Drug Designation to ALN-TTR02 as a therapeutic for the treatment of familial amyloidotic polyneuropathy (FAP), one of the predominant clinical manifestations of transthyretin (TTR)-mediated amyloidosis (ATTR).
The American Association of Critical-Care Nurses has recognized the Medical/Surgical Intensive Care Unit and Neonatal Intensive Care Unit at Children's Hospital Boston with gold-level Beacon Awards for Excellence.
› Verified 2 days ago
News Archive
The U.S. Food and Drug Administration today approved a new medical adhesive (a fibrin sealant) called Artiss for use in attaching skin grafts onto burn patients.
The COVID-19 pandemic caused by SARS-CoV-2 has been observed to be less serious in infants and children. However, this age group is also subject to certain complications following infection. A new study describes the findings of an observational study of children hospitalized with SARS-CoV-2 infection in several different hospitals across three countries.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the U.S. Food & Drug Administration (FDA) has provided Orphan Drug Designation to ALN-TTR02 as a therapeutic for the treatment of familial amyloidotic polyneuropathy (FAP), one of the predominant clinical manifestations of transthyretin (TTR)-mediated amyloidosis (ATTR).
The American Association of Critical-Care Nurses has recognized the Medical/Surgical Intensive Care Unit and Neonatal Intensive Care Unit at Children's Hospital Boston with gold-level Beacon Awards for Excellence.
› Verified 2 days ago
Drs Price Young Odle & Horsch Pa Type: Medicare Supplier Location: 109 S 6th St, Hiawatha, Kansas 66434 Phone: (636) 200-4393 | |
Eric C Mcpeak, Od Type: Medicare Supplier Location: 706 Oregon St, Hiawatha, Kansas 66434 Phone: (785) 742-3021 | |
Tice Healthmart Type: Medicare Supplier Location: 618 Oregon St, Hiawatha, Kansas 66434 Phone: (785) 742-2191 | |
Kex Rx Pharmacy And Home Care Type: Long Term Care Pharmacy Location: 101 S 6th St, Hiawatha, Kansas 66434 Phone: (785) 742-2125 | |
Personal Care Inc Type: DME Supplier - Oxygen Equipment & Supplies Location: 700 Oregon St, Hiawatha, Kansas 66434 Phone: (785) 742-7495 |